UBR1 as therapeutic target for anaplastic thyroid carcinoma
Sep. 3, 2024
Scientists from Wuhan University and affiliated organizations have published findings from their investigation into the role of Yes-associated protein (YAP), which is a critical effector of the Hippo pathway, in anaplastic thyroid carcinoma.